Published on in Vol 12 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/39455, first published
.

Journals
- Tsiakalos A, Ziakas P, Polyzou E, Schinas G, Akinosoglou K. Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis. Microorganisms 2023;11(8):2073 View
- Gao Z, Dorney I, Davis P, Kaelber D, Xu R. Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease. Journal of Alzheimer’s Disease 2024;102(1):99 View